7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Tooth Mobility D014086 2 associated lipids
Hyperparathyroidism D006961 3 associated lipids
Glucose Metabolism Disorders D044882 3 associated lipids
Cryptosporidiosis D003457 3 associated lipids
Carcinoma, Papillary D002291 3 associated lipids
Myositis, Inclusion Body D018979 3 associated lipids
Mitral Valve Stenosis D008946 3 associated lipids
Takayasu Arteritis D013625 3 associated lipids
Addison Disease D000224 3 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Multiple Sclerosis, Chronic Progressive D020528 3 associated lipids
Hirsutism D006628 3 associated lipids
Arthritis, Psoriatic D015535 3 associated lipids
Mastocytoma D034801 3 associated lipids
Progeria D011371 3 associated lipids
Arthritis, Reactive D016918 3 associated lipids
Hearing Loss D034381 3 associated lipids
Periapical Granuloma D010484 3 associated lipids
Respirovirus Infections D010253 3 associated lipids
Osteitis Deformans D010001 3 associated lipids
Measles D008457 3 associated lipids
Malocclusion D008310 3 associated lipids
Arthritis, Rheumatoid D001172 3 associated lipids
Paraneoplastic Syndromes D010257 4 associated lipids
Biliary Atresia D001656 4 associated lipids
Endocrine System Diseases D004700 4 associated lipids
Carcinoma, Lobular D018275 4 associated lipids
Mitral Valve Insufficiency D008944 4 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Temporomandibular Joint Disorders D013705 4 associated lipids
Fractures, Bone D050723 4 associated lipids
Periapical Diseases D010483 4 associated lipids
Osteoarthritis D010003 4 associated lipids
Diabetes Complications D048909 4 associated lipids
Tinnitus D014012 4 associated lipids
Histiocytosis, Non-Langerhans-Cell D015616 4 associated lipids
Osteoporosis, Postmenopausal D015663 4 associated lipids
Hyperparathyroidism, Secondary D006962 4 associated lipids
Jaw Diseases D007571 4 associated lipids
Heart Valve Diseases D006349 4 associated lipids
Hypercalciuria D053565 4 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Osteoarthritis, Hip D015207 4 associated lipids
Macular Degeneration D008268 5 associated lipids
Diabetic Neuropathies D003929 5 associated lipids
Bone Neoplasms D001859 5 associated lipids
beta-Thalassemia D017086 5 associated lipids
Femur Head Necrosis D005271 5 associated lipids
Calcinosis D002114 5 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Mandibular Diseases D008336 5 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Hot Flashes D019584 5 associated lipids
Osteonecrosis D010020 5 associated lipids
Sclerosis D012598 5 associated lipids
Graves Disease D006111 6 associated lipids
Malnutrition D044342 6 associated lipids
Acromegaly D000172 6 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Coronary Stenosis D023921 6 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Periapical Periodontitis D010485 6 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Dental Pulp Necrosis D003790 6 associated lipids
Dyslipidemias D050171 7 associated lipids
Periodontal Attachment Loss D017622 7 associated lipids
Chronic Disease D002908 7 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Carcinosarcoma D002296 7 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Bone Resorption D001862 7 associated lipids
Hepatitis C D006526 7 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Diabetes, Gestational D016640 8 associated lipids
Arthralgia D018771 8 associated lipids
Irritable Bowel Syndrome D043183 8 associated lipids
Thyroid Diseases D013959 8 associated lipids
Osteolysis D010014 8 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Obesity, Morbid D009767 8 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Mucocutaneous Lymph Node Syndrome D009080 9 associated lipids
Periodontal Pocket D010514 9 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Bone Diseases, Metabolic D001851 9 associated lipids
Bacteremia D016470 9 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Osteitis D010000 10 associated lipids
Vision Disorders D014786 10 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Alveolar Bone Loss D016301 10 associated lipids
Hemophilia A D006467 10 associated lipids
Cardiomyopathies D009202 10 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Sepsis D018805 11 associated lipids
Aortic Diseases D001018 11 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Scholtysek C et al. PPARβ/δ governs Wnt signaling and bone turnover. 2013 Nat. Med. pmid:23542786
Stuss M et al. Assessment of OPG/RANK/RANKL gene expression levels in peripheral blood mononuclear cells (PBMC) after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. 2013 J. Clin. Endocrinol. Metab. pmid:23543663
Winther S et al. Osteoprotegerin and mortality in hemodialysis patients with cardiovascular disease. 2013 Clin. Nephrol. pmid:23547804
Peng X et al. Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer. 2013 PLoS ONE pmid:23516466
Zhang Y et al. Expression of leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) on osteoclasts and its potential role in rheumatoid arthritis. 2013 Clinics (Sao Paulo) pmid:23778340
Liu M et al. Semen Astragali Complanati- and Rhizoma Cibotii-enhanced bone formation in osteoporosis rats. 2013 BMC Complement Altern Med pmid:23782721
Shen Q et al. Curculigoside promotes osteogenic differentiation of bone marrow stromal cells from ovariectomized rats. 2013 J. Pharm. Pharmacol. pmid:23738728
Liao C and Hua Y Effect of hydrogen sulphide on the expression of osteoprotegerin and receptor activator of NF-κB ligand in human periodontal ligament cells induced by tension-force stimulation. 2013 Arch. Oral Biol. pmid:24200305
Fontes JD et al. Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study. 2013 Atherosclerosis pmid:23489346
Oliver JL et al. Differential expression and tumor necrosis factor-mediated regulation of TNFRSF11b/osteoprotegerin production by human melanomas. 2013 Pigment Cell Melanoma Res pmid:23490134
Maïmoun L et al. Peripubertal female athletes in high-impact sports show improved bone mass acquisition and bone geometry. 2013 Metab. Clin. Exp. pmid:23490587
Cao H et al. Preoperative serum soluble receptor activator of nuclear factor-κB ligand and osteoprotegerin predict postoperative atrial fibrillation in patients undergoing cardiac valve surgery. 2013 Ann. Thorac. Surg. pmid:23870696
Dahl JS et al. Relation of osteoprotegerin in severe aortic valve stenosis to postoperative outcome and left ventricular function. 2013 Am. J. Cardiol. pmid:23871267
Zhu J et al. The influence of g.19124G>a genetic polymorphism in the OPG gene on bone mineral density in Chinese women. 2013 Genet Test Mol Biomarkers pmid:23837846
Salbach-Hirsch J et al. The promotion of osteoclastogenesis by sulfated hyaluronan through interference with osteoprotegerin and receptor activator of NF-κB ligand/osteoprotegerin complex formation. 2013 Biomaterials pmid:23871544
Zhou S et al. Osteoprotegerin inhibits calcification of vascular smooth muscle cell via down regulation of the Notch1-RBP-Jκ/Msx2 signaling pathway. 2013 PLoS ONE pmid:23874840
Zhong Z et al. Comparison of the biological response of osteoblasts after tension and compression. 2013 Eur J Orthod pmid:21402736
Napimoga MH et al. Low doses of 15d-PGJ2 induce osteoblast activity in a PPAR-gamma independent manner. 2013 Int. Immunopharmacol. pmid:23597428
Bradaschia-Correa V et al. Reduced RANKL expression impedes osteoclast activation and tooth eruption in alendronate-treated rats. 2013 Cell Tissue Res. pmid:23636419
Chandran V et al. Soluble biomarkers associated with response to treatment with tumor necrosis factor inhibitors in psoriatic arthritis. 2013 J. Rheumatol. pmid:23637322
Ming LG et al. The prenyl group contributes to activities of phytoestrogen 8-prenynaringenin in enhancing bone formation and inhibiting bone resorption in vitro. 2013 Endocrinology pmid:23389955
Piatek S et al. Multiparameter analysis of serum levels of C-telopeptide crosslaps, bone-specific alkaline phosphatase, cathepsin K, osteoprotegerin and receptor activator of nuclear factor κB ligand in the diagnosis of osteoporosis. 2013 Maturitas pmid:23391500
Biscetti F et al. Association between TNFRSF11B gene polymorphisms and history of ischemic stroke in Italian diabetic patients. 2013 Hum. Genet. pmid:22965192
Pereira GB et al. Acute effects of resistance training on cytokines and osteoprotegerin in women with metabolic syndrome. 2013 Clin Physiol Funct Imaging pmid:23383690
Benslimane-Ahmim Z et al. Mechanistic study of the proangiogenic effect of osteoprotegerin. 2013 Angiogenesis pmid:23386104
Cody JJ et al. Expression of osteoprotegerin from a replicating adenovirus inhibits the progression of prostate cancer bone metastases in a murine model. 2013 Lab. Invest. pmid:23358109
Wang Y et al. The effect of adenovirus-mediated siRNA targeting BMPR-II on UHMWPE-induced osteoclast formation. 2013 Biomaterials pmid:23079666
Giganti MG et al. Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures. 2012 Oct-Dec J. Biol. Regul. Homeost. Agents pmid:23241117
Heitzer E et al. IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancer. 2012 Nov-Dec Pain Physician pmid:23159968
Nuño-Arana I et al. Distribution of three SNPs related to low bone mineral density in Amerindian groups and Mestizos from Mexico. 2012 Jul-Aug Am. J. Hum. Biol. pmid:22434650
Varsavsky M et al. Serum osteoprotegerin and sex steroid levels in patients with prostate cancer. 2012 Jul-Aug J. Androl. pmid:21903971
Dalezis P et al. Dexamethasone plus octreotide regimen increases anticancer effects of docetaxel on TRAMP-C1 prostate cancer model. 2012 Jan-Feb In Vivo pmid:22210719
Ambroszkiewicz J et al. [Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis]. 2012 Apr-Jun Med Wieku Rozwoj pmid:22971655
Mogelvang R et al. Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis. 2012 Am. J. Cardiol. pmid:22100028
Chung E and Rylander MN Response of preosteoblasts to thermal stress conditioning and osteoinductive growth factors. 2012 Cell Stress Chaperones pmid:22116637
Li J et al. Effect of oscillating fluid flow stimulation on osteocyte mRNA expression. 2012 J Biomech pmid:22119108
Tanaka M et al. Alteration of Dickkopf-1 and receptor activator of nuclear factor-κB ligand during PBSC mobilization in healthy donors by G-CSF. 2012 Bone Marrow Transplant. pmid:22120987
Blázquez-Medela AM et al. Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes. 2012 Eur. J. Clin. Invest. pmid:22050177
Xu S et al. Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis. 2012 Rheumatol. Int. pmid:22057136
Ermakov S et al. A significant association exists between receptor tyrosine kinase-like orphan receptor 2 gene variants and the OPG/RANKL ratio in human plasma. 2012 Osteoporos Int pmid:22057548
Ueland T et al. TNF revisited: osteoprotegerin and TNF-related molecules in heart failure. 2012 Curr Heart Fail Rep pmid:22453763
Bogliolo L et al. Biomarkers and prognostic stratification in psoriatic arthritis. 2012 Reumatismo pmid:22690385
Olesen M et al. No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells. 2012 Mol. Cell. Endocrinol. pmid:22698523
Cvija H et al. Chemotactic and immunoregulatory properties of bone cells are modulated by endotoxin-stimulated lymphocytes. 2012 Inflammation pmid:22699680
Liu L et al. Protective effect of metformin on periapical lesions in rats by decreasing the ratio of receptor activator of nuclear factor kappa B ligand/osteoprotegerin. 2012 J Endod pmid:22703658
Nakashima T et al. New insights into osteoclastogenic signaling mechanisms. 2012 Trends Endocrinol. Metab. pmid:22705116
Duarte PM et al. Expression of immune-inflammatory markers in sites of chronic periodontitis in patients with type 2 diabetes. 2012 J. Periodontol. pmid:21859322
Ford ML et al. FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart. 2012 Nephrol. Dial. Transplant. pmid:21750158
Chai YC et al. Ectopic bone formation by 3D porous calcium phosphate-Ti6Al4V hybrids produced by perfusion electrodeposition. 2012 Biomaterials pmid:22381474
Hudson JB et al. Local delivery of recombinant osteoprotegerin enhances postorthodontic tooth stability. 2012 Calcif. Tissue Int. pmid:22382900
Singh DK et al. Prevalence and progression of peripheral vascular calcification in type 2 diabetes subjects with preserved kidney function. 2012 Diabetes Res. Clin. Pract. pmid:22386825
Jia P et al. The effect of alendronate on the expression of osteopontin and osteoprotegerin in calcified aortic tissue of the rat. 2012 Eur. J. Pharmacol. pmid:22387856
Eleftheriadis T et al. Inverse association of serum 25-hydroxyvitamin D with markers of inflammation and suppression of osteoclastic activity in hemodialysis patients. 2012 Iran J Kidney Dis pmid:22388612
Heymann MF et al. Role of the OPG/RANK/RANKL triad in calcifications of the atheromatous plaques: comparison between carotid and femoral beds. 2012 Cytokine pmid:22402034
Sun C et al. [Acqusition of full-length gene for rabbit osteoprotegerin]. 2012 Sheng Wu Yi Xue Gong Cheng Xue Za Zhi pmid:22404020
Quan J et al. Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma. 2012 Pathology pmid:22406484
Renno AC et al. Ultrasound therapy modulates osteocalcin expression during bone repair in rats. 2012 Ultrasonics pmid:21820693
Bergström I et al. Physical training increases osteoprotegerin in postmenopausal women. 2012 J. Bone Miner. Metab. pmid:21823052
Wang JQ et al. [Effects of static magnetic field at different times on the proliferation and differentiation of osteoblasts in vitro]. 2012 Zhongguo Gu Shang pmid:23427595
Singh PP et al. Membrane-bound receptor activator of NFκB ligand (RANKL) activity displayed by osteoblasts is differentially regulated by osteolytic factors. 2012 Biochem. Biophys. Res. Commun. pmid:22561018
Aronis KN et al. Secretion patterns of circulating osteoprotegerin and response to acute and chronic energy deprivation in young healthy adults. 2012 J. Clin. Endocrinol. Metab. pmid:22563105
Djamiatun K et al. Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13. 2012 PLoS Negl Trop Dis pmid:22563509
Taddei SR et al. Role of CCR2 in orthodontic tooth movement. 2012 Am J Orthod Dentofacial Orthop pmid:22284282
Karieb S and Fox SW Zinc modifies the effect of phyto-oestrogens on osteoblast and osteoclast differentiation in vitro. 2012 Br. J. Nutr. pmid:22289672
Niu YB et al. The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action. 2012 Osteoporos Int pmid:22535190
Wieczorek-Baranowska A et al. Osteocalcin and glucose metabolism in postmenopausal women subjected to aerobic training program for 8 weeks. 2012 Metab. Clin. Exp. pmid:22000586
Ostrowska Z et al. RANKL/RANK/OPG system and bone status in females with anorexia nervosa. 2012 Bone pmid:22001124
Kam WW et al. The 18 kDa translocator protein (peripheral benzodiazepine receptor) expression in the bone of normal, osteoprotegerin or low calcium diet treated mice. 2012 PLoS ONE pmid:22295097
Martin CK et al. Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma. 2012 Oral Oncol. pmid:22265717
Reginster JY et al. Strontium ranelate treatment increases osteoprotegerin serum levels in postmenopausal osteoporotic women. 2012 Bone pmid:22270053
Garlet GP et al. Expression analysis of wound healing genes in human periapical granulomas of progressive and stable nature. 2012 J Endod pmid:22244633
Makras P et al. Serum osteoprotegerin, RANKL, and Dkk-1 levels in adults with Langerhans cell histiocytosis. 2012 J. Clin. Endocrinol. Metab. pmid:22278426
Stępień E et al. Osteoprotegerin, but not osteopontin, as a potential predictor of vascular calcification in normotensive subjects. 2012 Hypertens. Res. pmid:22278625
Cauley JA Commentary: A single biomarker in a complex metabolic pathway. 2012 Int J Epidemiol pmid:22933649
Deuell KA et al. RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-α. 2012 J. Vasc. Res. pmid:22948607
Li F et al. Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells. 2012 Fitoterapia pmid:22951288
Buckle CH et al. Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma. 2012 PLoS ONE pmid:22952578
Shen P et al. Expression of osteoprotegerin in placenta and its association with preeclampsia. 2012 PLoS ONE pmid:22952959
Diercke K et al. IL-1β and compressive forces lead to a significant induction of RANKL-expression in primary human cementoblasts. 2012 J Orofac Orthop pmid:22955577
Chen J et al. OPG inhibits gene expression of RANK and CAII in mouse osteoclast-like cell. 2012 Rheumatol. Int. pmid:22210270
Giannopoulou C et al. Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis. 2012 Acta Odontol. Scand. pmid:22214279
Bloch SL and Sørensen MS Otosclerosis: a perilabyrinthine threshold phenomenon. 2012 Acta Otolaryngol. pmid:22217131
Wang S and Liu YS [Advance on arterial calcification]. 2012 Sheng Li Ke Xue Jin Zhan pmid:23189619
Rashtchizadeh N et al. Serum receptor activator of nuclear factor-κ B ligand, osteoprotegrin, and intact parathyroid hormone in hemodialysis and renal transplant patients. 2012 Ther Apher Dial pmid:23190522
Pecchi E et al. A potential role of chondroitin sulfate on bone in osteoarthritis: inhibition of prostaglandin E₂ and matrix metalloproteinases synthesis in interleukin-1β-stimulated osteoblasts. 2012 Osteoarthr. Cartil. pmid:22179028
Xue Y et al. Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions. 2012 PLoS ONE pmid:23144698
Adamczyk T et al. Biomarkers of calcification and atherosclerosis in patients with degenerative aortic stenosis in relation to concomitant coronary artery disease. 2012 Pol. Arch. Med. Wewn. pmid:22237719
Nyrnes A et al. Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study. 2012 Gend Med pmid:23046763
Brandenburg V et al. Calcification inhibitors in vascular calciphylaxis associated with normal renal function. 2012 Thromb. Haemost. pmid:23092963
Ryser MD et al. Osteoprotegerin in bone metastases: mathematical solution to the puzzle. 2012 PLoS Comput. Biol. pmid:23093918
Kleyer A et al. Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss. 2012 J. Bone Miner. Res. pmid:22806960
Giaginis C et al. Correlation of plasma osteoprotegerin (OPG) and receptor activator of the nuclear factor κB ligand (RANKL) levels with clinical risk factors in patients with advanced carotid atherosclerosis. 2012 Med. Sci. Monit. pmid:23018352
Wang C et al. Susceptibility genes for osteoporotic fracture in postmenopausal Chinese women. 2012 J. Bone Miner. Res. pmid:22807154
Martínez E et al. Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir. 2012 AIDS pmid:23018438
Poerschke RL et al. Major differences among chemopreventive organoselenocompounds in the sustained elevation of cytoprotective genes. 2012 J. Biochem. Mol. Toxicol. pmid:22807314
Thadani U Osteoprotegerin and ST segment myocardial infarction: a novel risk marker but not for routine use at present. 2012 Cardiology pmid:23018624
Chandran V Soluble biomarkers may differentiate psoriasis from psoriatic arthritis. 2012 J Rheumatol Suppl pmid:22751596
Melchiorre D et al. RANK-RANKL-OPG in hemophilic arthropathy: from clinical and imaging diagnosis to histopathology. 2012 J. Rheumatol. pmid:22753650
Zhou W and Mei L Effect of autologous bone marrow stromal cells transduced with osteoprotegerin on periodontal bone regeneration in canine periodontal window defects. 2012 Int J Periodontics Restorative Dent pmid:22754911
Baud'huin M et al. A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22761317

Table of Content